Understand this story
On November 20, 2026, OpenAI launched MedChemBench, a medicinal chemistry reasoning benchmark designed to evaluate AI models’ reasoning capabilities in tasks including molecular structure analysis, scientific explanation, compound selection, and property prediction. The benchmark comprises 99 questions drawn from 117 papers and patents and covers 761 molecular structures. At the xhigh reasoning setting, GPT-6.2 Astra achieved a usable score of 84.5%. The model performed strongly in reconstructing molecular structures and explaining experimental evidence, but still has room for improvement in compound screening and numerical property prediction. No evidence-supported subsequent developments have been identified at present.
AI-generated from public reports
Latest development · Report
OpenAI Launches MedChemBench to Evaluate AI-Assisted Drug Development CapabilitiesDevelopments
1 confirmed developments
Reports and discussion timeline
Browse reports and discussion by time. Their evidence levels remain distinct.
Nov 21
ITHome · Artificial Intelligence
OpenAI Launches MedChemBench to Evaluate AI-Assisted Drug Development Capabilities
OpenAI has released MedChemBench to evaluate AI models’ reasoning capabilities in medicinal chemistry research, covering molecular structures, scientific explanations, compound selection, and property prediction. The benchmark contains 99 questions drawn from 117 papers and patents, involving 761 molecular structures; at the xhigh reasoning level, GPT-6.2 Astra achieved a usable score of 84.5%. The model performed strongly in reconstructing molecular structures and explaining experimental evidence, but still has considerable room for improvement in compound screening and numerical property prediction.
IT Home · AIRelated discussion
IT Home · AI joined this discussion
This post contributes to heat; it is not a formal report or confirmed fact.
Phoenix Technology
OpenAI Launches MedChemBench to Evaluate AI Capabilities in Assisting Medicinal Chemistry Research
OpenAI has released MedChemBench to evaluate AI models' reasoning capabilities in medicinal chemistry research. The benchmark includes 99 questions drawn from 117 papers and patents, covering 761 distinct molecular structures. At the xhigh reasoning setting, GPT-6.2 Astra, GPT-6 Astra, GPT-6.1 Sol, and GPT-5.6 Sol achieved usable scores of 84.5%, 83.3%, 82.0%, and 58.2%, respectively. The models performed strongly in molecular structure reconstruction, but there remains substantial room for improvement in compound selection and numerical property prediction. The results also cannot establish whether the models can discover new drugs or improve laboratory decision-making.
Rohan Paul
OpenAI Releases MedChemBench, a Medicinal Chemistry Benchmark
OpenAI has released MedChemBench, a medicinal chemistry benchmark whose questions are drawn from 117 papers and patents and cover 761 scored molecular structures, with results later reported by researchers withheld. Each prompt stops at a real-world decision point and provides a biological target, existing compounds, and partial assay results. The best-performing model, GPT-6.2 Astra, scored about 84% overall and was nearly perfect at reading chemical information, but made the correct judgment only about half the time on critical decisions.
Greg Brockman
MedChemBench Measures Progress in Medicinal Chemistry Reasoning
OpenAI says MedChemBench is a new benchmark for evaluating AI reasoning in medicinal chemistry, demonstrating the progress its frontier models have made in helping scientists identify promising drug candidates. Greg Brockman commented that the advances AI has made in this field are remarkable.
Unite.AI
OpenAI Launches MedChemBench, a Medicinal Chemistry Reasoning Benchmark
OpenAI has launched MedChemBench, a medicinal chemistry reasoning benchmark comprising 99 questions, and reports that GPT-6.2 Astra achieved a usable score of 84.5% at xhigh reasoning effort. The tasks were drawn from 117 papers and patents and cover 761 independently scored molecular structures, with a focus on evaluating models' ability to combine molecular structures with experimental data for explanation, comparison, and property prediction. The results show that the model performs strongly in structure reconstruction and scientific explanation, but is relatively weaker at candidate compound selection and numerical prediction. Moreover, the benchmark does not demonstrate that the model can discover new drugs or improve laboratory decision-making.
OpenAIFirst-party
OpenAI Launches Medicinal Chemistry Reasoning Evaluation
MedChemBench is a new evaluation benchmark for AI reasoning in medicinal chemistry. OpenAI says it demonstrates the progress its frontier models have made in helping scientists use AI to identify promising drug candidates.
Heat trend for this story
- Current
- 29
- Period peak
- 35 Nov 21 10:00
- 24-hour change
- +48%
Move the pointer or select the chart to inspect hourly heat. Use the left and right arrow keys with a keyboard.
AI Trends